Search

everythinglearnresearchcommunity

for

Search:↓

RCM and OCT are effective for diagnosing and monitoring hair-related skin diseases but lack standardized protocols and need more research.

Some drugs, especially biologics, can cause skin reactions that look like other skin diseases, and stopping the drug usually helps clear up these reactions.

The document concludes that accurate diagnosis of hair loss in children is crucial due to limited treatment options and the condition's psychological impact.

Up to half of adult women may experience hair loss, and doctors should use medical history, exams, and tests to find the cause and treat it.

Hair loss in women is complex to diagnose and treat, and hair restoration should be done by experts. Using minoxidil before surgery can help manage post-surgery hair shock loss. The Follicular Unit Transplantation method is recommended for women due to its speed, no need for shaving, and better graft quality. Strategies like L, T, and reverse L patterns can help restore central hair density, and regenerative methods can improve graft survival in hair transplants.

There have been major advances in diagnosing and treating hair loss over the last 30 years, with new drugs and improved hair transplant techniques.

Fungal infection was the main cause of hair loss in Egyptian children studied.

The International Society of Hair Restoration Surgery created a standard curriculum in 2008 to guide doctors in diagnosing and treating hair loss effectively.

Low iron and vitamin D levels are linked to hair loss in women.

The Cross-section Trichometer is a new tool that can measure hair quantity and detect hair loss and growth.

Videodermoscopy better identifies female hair loss than clinical diagnosis.

Dr. Shyam B Verma encourages more scientific research on hair disorders and criticizes the unscientific hair care market in India.

The document explains how to claim CME credit by diagnosing and treating hair loss conditions in two patient cases.

The Hair India 2010 conference introduced a new hair loss classification and highlighted advanced diagnostic techniques in trichology.

Different hair evaluation methods have their own pros and cons, and using multiple methods together is best for accurate hair loss diagnosis and tracking.

Some drugs can cause reversible hair loss, but certain chemotherapy drugs may lead to permanent hair loss; drugs can also change hair color and texture.

Female pattern hair loss diagnosis is challenging and should use dermoscopy and histopathology instead of pattern recognition, as hormones may not always be the cause.

The research created a model to understand human hair growth cycle, which can help diagnose and treat hair growth disorders and test potential hair growth drugs.

New treatments for hair loss could involve using stem cells and a process called the Wnt/beta-catenin pathway to stimulate hair growth.

Scalp biopsies are essential for accurately diagnosing alopecia areata.

Standardized data is essential for diagnosing scalp and hair conditions in males.

A 12-year-old boy's hair fully regrew after 8 weeks of treatment for tinea capitis, and dermoscopy was useful for diagnosis and monitoring.

The document concludes that it's important to recognize and treat hair loss in women of color, considering their unique hair characteristics and psychological impact.

Trichoscopy is not specific for diagnosing telogen effluvium and both telogen effluvium and androgenetic alopecia often occur together.

Androgenetic alopecia causes hair thinning due to increased androgen activity, treatable with minoxidil and finasteride.

Dermoscopy is effective for diagnosing various skin infestations and infections.

Sertraline can cause hair loss, which stops after stopping the drug.

Some congenital hair disorders improve in childhood or with treatments like minoxidil and retinoids, while others like Netherton syndrome and trichothiodystrophy have a poor prognosis.

The document concludes that hair analysis is not good for assessing nutrition but can detect long-term heavy metal exposure.

Activating the Wnt/β-catenin pathway could lead to new hair loss treatments.